MYCOPHENOLATE MOFETIL VS CYCLOPHOSPHAMIDE IN SCLERODERMA ASSOCIATED INTERSTITIAL LUNG DISEASE(ILD) - SINGLE CENTER OBSERVATIONAL STUDY

被引:0
|
作者
Bavaliya, M. [1 ]
Padmanabha, S. [1 ]
机构
[1] Amrita Inst Med Scienece, Kochi, Kerala, India
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ARP85
引用
收藏
页码:34 / 34
页数:1
相关论文
共 50 条
  • [21] Cyclophosphamide for scleroderma interstitial lung disease
    Antoniu, Sabina A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (03) : 393 - 395
  • [22] Mycophenolate Mofetil for Interstitial Lung Disease in Dermatomyositis
    Morganroth, Pamela A.
    Kreider, Mary Elizabeth
    Werth, Victoria P.
    ARTHRITIS CARE & RESEARCH, 2010, 62 (10) : 1496 - 1501
  • [23] Interstitial lung disease treated with mycophenolate mofetil
    Megan Cully
    Nature Reviews Rheumatology, 2013, 9 (4) : 198 - 198
  • [24] Randomized control multi-center clinical study of mycophenolate mofetil and cyclophosphamide in the treatment of connective tissue disease related interstitial lung disease
    张光峰
    ChinaMedicalAbstracts(InternalMedicine), 2016, 33 (01) : 56 - 57
  • [25] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Koutroumpas, Athanasios
    Ziogas, Athanasios
    Alexiou, Ioannis
    Barouta, Georgia
    Sakkas, Lazaros I.
    CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1167 - 1168
  • [26] Treatment of Scleroderma Associated Lung Disease with Mycophenolate Mofetil: A Community-Based Study.
    Bearden, Audrey
    Huston, Kent Kwasind
    Foxworth, Judy
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S741 - S741
  • [27] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Athanasios Koutroumpas
    Athanasios Ziogas
    Ioannis Alexiou
    Georgia Barouta
    Lazaros I. Sakkas
    Clinical Rheumatology, 2010, 29 : 1167 - 1168
  • [28] IMPACT OF HOSPITALIZATION ON CLINICAL OUTCOMES IN PATIENTS WITH CONNECTIVE TISSUE DISEASE ASSOCIATED INTERSTITIAL LUNG DISEASE (CTD-ILD) - A SINGLE CENTER OBSERVATIONAL STUDY
    Kaur, N.
    Xie, X.
    Korogodina, A.
    Ayesha, B.
    Cleven, K.
    Kumthekar., A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1816 - 1816
  • [29] Usefulness of pulsed cyclophosphamide in Interstitial Lung Disease (ILD)
    Kong, Chia Wei
    Adeagbo, Oluwatobi
    Hooper, Robert
    Titmuss, Vanessa
    Babu, Suresh
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [30] Telomere (TL) shortening is associated with disease severity in scleroderma (SSC) associated interstitial lung disease (ILD)
    Adamali, Huzaifa I.
    Delgado, Cesar M.
    Stock, Carmel
    Lindhal, Gisela E.
    Molyneaux, Phil
    Russell, Anne-Marie
    Wells, Athol
    Renzoni, Elizabeth A.
    Maher, Toby
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40